10.25384/SAGE.6474014.v1
Steve Deitelzweig
Steve
Deitelzweig
Xuemei Luo
Xuemei
Luo
Kiran Gupta
Kiran
Gupta
Jeffrey Trocio
Jeffrey
Trocio
Jack Mardekian
Jack
Mardekian
Tammy Curtice
Tammy
Curtice
Patrick Hlavacek
Patrick
Hlavacek
Melissa Lingohr-Smith
Melissa
Lingohr-Smith
Brandy Menges
Brandy
Menges
Jay Lin
Jay
Lin
Supplemental Material, Apix_vs_Riva_Dabi_Warf_HRU_CATH_manuscript_v9_Supp_Table - All-Cause, Stroke/Systemic Embolism–, and Major Bleeding-Related Health-Care Costs Among Elderly Patients With Nonvalvular Atrial Fibrillation Treated With Oral Anticoagulants
SAGE Journals
2018
elderly
nonvalvular atrial fibrillation
oral anticoagulants
apixaban
rivaroxaban
dabigatran
warfarin
stroke
systemic embolism
major bleeding
health-care costs
2018-01-24 12:00:00
Journal contribution
https://sage.figshare.com/articles/journal_contribution/Supplemental_Material_Apix_vs_Riva_Dabi_Warf_HRU_CATH_manuscript_v9_Supp_Table_-_All-Cause_Stroke_Systemic_Embolism_and_Major_Bleeding-Related_Health-Care_Costs_Among_Elderly_Patients_With_Nonvalvular_Atrial_Fibrillation_Treated_With_Oral_Anticoagulants/6474014
<p>Supplemental Material, Apix_vs_Riva_Dabi_Warf_HRU_CATH_manuscript_v9_Supp_Table for All-Cause, Stroke/Systemic Embolism–, and Major Bleeding-Related Health-Care Costs Among Elderly Patients With Nonvalvular Atrial Fibrillation Treated With Oral Anticoagulants by Steve Deitelzweig, Xuemei Luo, Kiran Gupta, Jeffrey Trocio, Jack Mardekian, Tammy Curtice, Patrick Hlavacek, Melissa Lingohr-Smith, Brandy Menges, and Jay Lin in Clinical and Applied Thrombosis/Hemostasis</p>